| Date | Time | Source | Headline | Symbol | Company |
| 05/26/2020 | 12:49PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 05/26/2020 | 11:22AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 05/26/2020 | 10:46AM | UK Regulatory | MaxCyte, Inc. Holdings in Company | LSE:MXCT | Maxcyte Inc |
| 05/21/2020 | 8:50AM | UK Regulatory | MaxCyte, Inc. Result of Special Meeting and Issue of Equity | LSE:MXCT | Maxcyte Inc |
| 05/18/2020 | 7:00AM | PR Newswire (US) | MaxCyte to Share Preliminary Phase I Data on MCY-M11 at ASCO 2020 Annual Meeting | LSE:MXCT | Maxcyte Inc |
| 05/14/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Poster Presentation on MCY-M11 at ASCO 2020 | LSE:MXCT | Maxcyte Inc |
| 05/07/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. License Agreement with Caribou Biosciences | LSE:MXCT | Maxcyte Inc |
| 05/01/2020 | 3:54AM | Alliance News |  MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO | LSE:MXCT | Maxcyte Inc |
| 05/01/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Result of Offering | LSE:MXCT | Maxcyte Inc |
| 04/30/2020 | 12:39PM | UK Regulatory | MaxCyte, Inc. Proposed Offering to raise up to GBP25.1 million | LSE:MXCT | Maxcyte Inc |
| 04/21/2020 | 11:59AM | Alliance News | MaxCyte Annual Loss Widens As Carma Investment Increases | LSE:MXCT | Maxcyte Inc |
| 04/21/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Final Results for Year Ended 31 December 2019 | LSE:MXCT | Maxcyte Inc |
| 04/09/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Business Update Related to COVID-19 Pandemic | LSE:MXCT | Maxcyte Inc |
| 03/24/2020 | 3:00AM | UK Regulatory | MaxCyte, Inc. License Agreement with Allogene Therapeutics | LSE:MXCT | Maxcyte Inc |
| 02/21/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Consolidation of Trading Lines | LSE:MXCT | Maxcyte Inc |
| 02/20/2020 | 1:18PM | UK Regulatory | MaxCyte, Inc. AIM Block Admission Return / Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 02/05/2020 | 2:00AM | RNS Non-Regulatory | MaxCyte, Inc. MaxCyte to Present at BIO CEO & Investor Conf | LSE:MXCT | Maxcyte Inc |
| 01/24/2020 | 11:31AM | UK Regulatory | MaxCyte, Inc. Grant Of Options | LSE:MXCT | Maxcyte Inc |
| 01/22/2020 | 12:15PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 01/22/2020 | 12:11PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 01/22/2020 | 12:08PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 01/20/2020 | 4:00AM | Alliance News | MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue | LSE:MXCT | Maxcyte Inc |
| 01/20/2020 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 12/19/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. New Executive Vice President and Trial Update | LSE:MXCT | Maxcyte Inc |
| 12/16/2019 | 12:25PM | UK Regulatory | MaxCyte, Inc. Director/PCA transaction initial notification | LSE:MXCT | Maxcyte Inc |
| 12/04/2019 | 6:50AM | Alliance News | MaxCyte Shares Rise As It Signs Development Deal With KSQ Therapeutics | LSE:MXCT | Maxcyte Inc |
| 12/04/2019 | 2:01AM | UK Regulatory | MaxCyte, Inc. Agreement with KSQ Therapeutics | LSE:MXCT | Maxcyte Inc |
| 11/21/2019 | 1:55PM | Alliance News | MaxCyte Inks Non-Exclusive Licence Agreement With Vor Biopharma | LSE:MXCT | Maxcyte Inc |
| 11/21/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Vor Biopharma Clinical and Commercial License | LSE:MXCT | Maxcyte Inc |
| 11/14/2019 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. Presentation at Jefferies Healthcare Conference | LSE:MXCT | Maxcyte Inc |